Intracerebroventricular administration of aggregated Aβ25–35 induces neuroinflammation, which is manifested by the activation of microglia and astrocytes, neuronal damage and cognitive impairments[51] and overproduction of IL-1 in activated microglia[52]. The gene discussed is IL1A; the disease is Cognitive impairment.